XKRX
234080
Market cap126mUSD
Oct 08, Last price
10,940.00KRW
1D
0.00%
1Q
-3.95%
Jan 2017
-20.00%
IPO
-36.21%
Name
JW Life Science Corp
Chart & performance
P/E
5.92
P/S
0.66
EPS
1,847.38
Div yield, %
—
Shrs. gr., 5y
-0.49%
Rev. gr., 5y
7.04%
Revenues
257.83b
+15.89%
Net income
28.61b
-34.97%
CFO
40.54b
-20.03%
Dividend
Mar 31, 2026550 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
JW Life Science Corp. manufactures intravenous fluids. Its products include basic IV, nutrition, special fluids, irrigation agents and dialysis solutions. The company was founded on May 10, 1994 and is headquartered in Dangjin-si, South Korea.
Key people
Cheol Won Park
Internal Auditor · since 2017
Jeong Yeol Noh
Chief Executive Officer, Director · since 2024
Jae Cheol Gwon
Non Executive Director
Yin Sik Lee
Non Executive Director
Hak Ju Kim
Non-Executive Independent Director · since 2024
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||